Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature | Zendy

Soheila Torabiyan | Zendy; Behnam Dalfardi | Zendy; Mojgan Sanjari | Zendy

Open Access

Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature

Author(s) -

Soheila Torabiyan,

Behnam Dalfardi,

Mojgan Sanjari

Publication year - 2021

Publication title -

case reports in endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.26

H-Index - 6

eISSN - 2090-6501

pISSN - 2090-651X

DOI - 10.1155/2021/2765867

Subject(s) - mucormycosis , medicine , diabetic ketoacidosis , asymptomatic , diabetes mellitus , dermatology , surgery , pediatrics , paranasal sinuses , ketoacidosis , amphotericin b , type 1 diabetes , antifungal , endocrinology

Mucormycosis is a lethal and life-threatening fungal infection. Several cases describing the association of COVID-19 and mucormycosis have been reported. In this article, we report a 58-year-old female with a history of diabetes mellitus type 2 who presented by diabetic ketoacidosis, rhino-orbital mucormycosis, and COVID-19. The patient was treated with liposomal amphotericin B and debridement of necrotic tissue of the rhino-orbital area and paranasal sinuses. Unfortunately, she passed away a few days after orbital surgery. We also conducted a review of the literature and reported 3 other similar cases that suffered from mucormycosis in association with COVID-19 and diabetic ketoacidosis and discussed the importance of this association.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research